Trademark Win for Mankind: HC Rejects FLORASIS Over Similarity with FLORA Farhat Nasim16 May 2025 12:17 PMNew Delhi: The Delhi High Court has set aside the registration of the trademark "FLORASIS" filed by Zhejiang Yige Enterprise Management Group Co....
DTAB Agrees to Prohibit 16 FDCs Identified as Irrational Farhat Nasim15 May 2025 3:32 PMDelhi: In a major move to strengthen drug safety and rational prescribing practices, the Drugs Technical Advisory Board (DTAB) has recommended a ban...
DCGI Told to Act Against Unapproved Antibiotic FDCs Farhat Nasim14 May 2025 2:18 PMNew Delhi: The Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, has taken a firm stance on curbing the irrational use of...
DTAB Recommends Ban on 34 Antimicrobials for Animal Use, Seeks Report on 3 Exceptions Dr. Divya Colin13 May 2025 12:30 PMNew Delhi: The Drug Technical Advisory Board (DTAB) has recommended banning the manufacture, import, sale, distribution, and use of 34 antimicrobial...
Bombay HC Notice to CDSCO on Denial of Phase I Trial for Indigenous Cancer Drug Farhat Nasim12 May 2025 12:37 PMMumbai: The Bombay High Court has issued a notice to the Central Drugs Standard Control Organisation (CDSCO) and the Union government following a...
DTAB Approves Notification System for Application of new drug, IND for clinical trial, BA-BE study Dr. Divya Colin11 May 2025 12:15 PMNew Delhi: With an aim to streamline the process for permission to manufacture new drugs and investigational new drugs (IND) for clinical trials,...
Delhi HC Clears Mankind Prime Labs' CROSSRELIEF Trademark for Registration Farhat Nasim10 May 2025 12:35 PMNew Delhi: In a major relief to Mankind Prime Labs Pvt. Ltd., a subsidiary of Mankind Pharma Ltd., the Delhi High Court has set aside the Trade Marks...
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac Farhat Nasim9 May 2025 2:21 PMEmpagliflozin plain and its combination with Linagliptin currently account for about 80% of total sales in this Rs 745 crore market.
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 8:44 AMNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
Dettol Controversy: Reckitt Settles with Influencer Raj Shamani, But To Proceed Legally Against Dermatologist Farhat Nasim7 May 2025 2:11 PMNew Delhi: Reckitt Benckiser, the company behind Dettol, has informed the Delhi High Court that it has reached a settlement with popular social media...
Ranitidine Under Scanner Again: DTAB, CDSCO Recommend New Safety Study, Tighter Monitoring Farhat Nasim6 May 2025 12:32 PMNew Delhi: Amid continued global concerns over the presence of N-nitrosodimethylamine (NDMA) impurities in ranitidine, the Drugs Technical Advisory...
Substandard Drugs to Face Immediate License Suspension Under DTAB's New Recommendation Farhat Nasim5 May 2025 11:46 AMNew Delhi: In a significant move to tighten quality control and safeguard public health, the Drugs Technical Advisory Board (DTAB) has recommended...
